SELE and prostate carcinoma: Moreover, the ex vivo interactions between CTCs isolated from patients and E-selectin on activated endothelial cells correlated with the clinical response of castration resistant prostate cancer patients, suggesting a dynamic modulation of selectin ligands expression as the disease develops to a more aggressive phenotype.